abstract |
The present invention relates to 4-indol-3-yl-N-phenyl, which is useful for treating cell proliferative diseases, treating diseases associated with MET activity, and inhibiting the receptor tyrosine kinase MET. It relates to pyrimidine-2-amine derivatives. The invention also relates to compositions comprising these compounds and methods of using them to treat cancer in mammals. |